Exploiting the synergy of registered drugs Rifampicin and Albendazole to shorten the treatment duration of Macrofilaricide for the cure of Onchocerciasis in areas co-endemic with Loiasis (ESRIFAL):
A pilot phase II Clinical Trial study
“This project (TMA2019SFP-2814) is part of the EDCTP2 programme supported by the European Union.”
Senior Fellow
Professor Samuel Wanji
University of Buea, Cameroon
Trainee Fellow
Dr Hamit Mahamat Mahamat Alio,
University of N’Djamena, Chad.
